Nanog Antibody, anti-human, pure, REAfinity™ | Miltenyi Biotec 130-104-732 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Miltenyi Biotec

product type :

antibody

product name :

Nanog Antibody, anti-human, pure, REAfinity™

catalog :

130-104-732

quantity :

100 µg in 1 mL

price :

176 USD

clonality :

monoclonal

host :

human

conjugate :

nonconjugated

clone name :

REA314

reactivity :

human

application :

flow cytometry

citations: 3

Reference
Costa Y, Ding J, Theunissen T, Faiola F, Hore T, Shliaha P, et al. NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature. 2013;495:370-4 pubmed publisher
Wang Z, Oron E, Nelson B, Razis S, Ivanova N. Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. Cell Stem Cell. 2012;10:440-54 pubmed publisher
Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 2003;113:643-55 pubmed

product information

MB Cataloge Number :

130-104-732

Catalog Number :

130-104-732

Product Name :

Nanog Antibody, anti-human, pure, REAfinity™

Product Type :

Primary antibodies, Recombinant antibodies

Host Species :

recombinant human IgG1

Clonality :

monoclonal

Conjugation :

pure

Antigen Modification :

Nanog

Clone Name :

REA314

Isotype :

REA Control Antibody (I), human IgG1

Size :

100 µg in 1 mL

US List Price :

176 USD

Product Description :

Identification and enumeration of Nanog+ cells by flow cytometry

ALTnames :

Homeobox protein NANOG, ES cell-associated protein 4, Early embryo specific expression NK-type homeobox protein, Homeobox transcription factor Nanog (hNanog)

Specificity :

human

Uses :

For research use only

Application Summary :

Intracellular flow cytometry

Storage :

Store protected from light at 2–8 °C. Do not freeze.